Endocarditis Clinical Awareness, Research, and Evaluation in Sweden (ENDO-CARE)
ENDO-CARE: Endocarditis Clinical Awareness, Research, and Evaluation in Sweden
The goal of this observational study is to improve the understanding of infective endocarditis by investigating clinical characteristics, treatment strategies, and short- and long-term outcomes in patients diagnosed with infective endocarditis in Sweden. The study includes all adults >18 years of age diagnosed with infective endocarditis in Sweden since 1997 through linkage of nationwide Swedish health data registers within the Endocarditis Clinical Awareness, Research and Evaluation in Sweden (ENDO-CARE) project. For each patient, four individuals from the general population matched on age and sex are included as population comparators.
The main questions it aims to answer are:
- Which patients with infective endocarditis benefit from valve surgery, and what is the optimal timing of surgery?
- Which patient-, disease-, microbiological-, and socioeconomic factors are associated with short- and long-term outcomes, including mortality, recurrent infective endocarditis, heart failure, stroke, and other major complications?
- How do long-term outcomes and life expectancy differ between patients with infective endocarditis and matched individuals from the general population?
- How have the incidence, management, microbiology, and outcomes of infective endocarditis changed over time?
Researchers will compare surgically and non-surgically treated patients, different clinical subgroups, and patients with infective endocarditis with matched population comparators to identify factors associated with treatment decisions, prognosis, and long-term outcomes.
Participants will not undergo any study-specific interventions or examinations. The study is based on linkage of existing nationwide Swedish health care and population registers, including data on hospital admissions, cardiac surgery, microbiology, prescribed medications, dental care, socioeconomic factors, and causes of death.
研究概览
地位
详细说明
Infective endocarditis (IE) is a rare but life-threatening disease associated with high morbidity and mortality despite advances in diagnostic methods, antimicrobial therapy, and cardiac surgery. Although current international guidelines provide recommendations concerning management of patients with infective endocarditis, many important clinical questions remain unanswered because randomized clinical trials are difficult to perform in this patient population. Consequently, most evidence is derived from observational studies, which are often limited by small sample sizes, selected patient populations, and relatively short follow-up.
The Endocarditis Clinical Awareness, Research and Evaluation in Sweden (ENDO-CARE) project is a nationwide research platform established to improve the understanding of infective endocarditis through comprehensive linkage of Swedish national health data registers. The ENDO-CARE database includes all patients diagnosed with infective endocarditis in Sweden since 1997. In addition, four matched individuals from the general population are included for each patient to enable comparisons of long-term outcomes and life expectancy with the background population.
The database integrates information from multiple nationwide registers, including hospital admissions, diagnoses, cardiac surgery, microbiology, echocardiographic findings, prescribed medications, socioeconomic factors, dental care, causes of death, and other population-based health registers. Individual-level linkage is performed using the unique Swedish personal identity number before data are pseudonymized for research purposes.
The overall objective of ENDO-CARE is to broaden the knowledge about endocarditis and to improve the evidence base for the management of infective endocarditis. Planned studies will investigate patient characteristics, microbiology, cardiac imaging findings, treatment strategies, and both short- and long-term outcomes.
Particular emphasis will be placed on:
- Evaluating indications for and timing of valve surgery
- Identifying patient groups that benefit most from surgical intervention
- Assessing temporal trends in incidence and management
- Investigating prognostic factors and risk stratification
- Evaluating long-term survival and life expectancy
- Studying disparities in care related to sex, age, and socioeconomic status.
The ENDO-CARE platform is designed to support multiple observational studies using modern epidemiological methods. The comprehensive nationwide design minimizes selection bias, enables complete follow-up through national registers, and allows the study of rare patient subgroups and clinically important outcomes that cannot readily be evaluated in randomized clinical trials.
The knowledge generated through ENDO-CARE is expected to improve risk stratification, support clinical decision-making regarding medical and surgical treatment, inform future national and international clinical guidelines, and ultimately contribute to more individualized and equitable care for patients with infective endocarditis.
研究类型
注册 (估计的)
联系人和位置
学习地点
-
-
-
Stockholm、瑞典
- Karolinska Institutet
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
The study population is derived from the Swedish National Patient Register and includes all patients diagnosed with infective endocarditis who received care within the Swedish healthcare system. Using the unique personal identity number assigned to all Swedish residents, several nationwide Swedish health data registers has been cross-linked to obtain further information about baseline characteristics including socioeconomic information, cardiac surgery, endocarditis specific information such as microbiology, cardiac imaging and prescribed antibiotics, survival status and hospital admissions during follow-up.
For each patient with infective endocarditis, four matched individuals from the general Swedish population are identified through the Swedish Population Register to serve as population comparators.
描述
Inclusion Criteria:
- Patients aged >18 years diagnosed with infective endocarditis in Sweden from January 1, 1997, and onwards, identified through nationwide Swedish health data registers.
- Individuals from the general population matched to patients with infective endocarditis (four comparators per patient) on age and sex.
Exclusion Criteria:
- Individuals with missing or invalid personal identity numbers precluding linkage between national registers.
- Individuals with incomplete or inconsistent registry information preventing determination of study eligibility or follow-up, where applicable to specific analyses.
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
Patients with infective endocarditis
|
|
Matched controls from the general population
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
All-cause mortality
大体时间:From index diagnosis until end of available follow-up (up to 28 years)
|
From index diagnosis until end of available follow-up (up to 28 years)
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Heart failure
大体时间:From index diagnosis until end of available follow-up (up to 28 years)
|
From index diagnosis until end of available follow-up (up to 28 years)
|
|
Stroke
大体时间:From index diagnosis until end of available follow-up (up to 28 years)
|
From index diagnosis until end of available follow-up (up to 28 years)
|
|
Major bleeding
大体时间:From index diagnosis until end of available follow-up (up to 28 years)
|
From index diagnosis until end of available follow-up (up to 28 years)
|
|
Re-infection
大体时间:From index diagnosis until end of available follow-up (up to 28 years)
|
From index diagnosis until end of available follow-up (up to 28 years)
|
|
Repeat valve surgery
大体时间:From index diagnosis until end of available follow-up (up to 28 years)
|
From index diagnosis until end of available follow-up (up to 28 years)
|
|
Cardiovascular death
大体时间:From index diagnosis until end of available follow-up (up to 28 years)
|
From index diagnosis until end of available follow-up (up to 28 years)
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2024-03639-01
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.